Daniel E McLoughlin, Nicholas Chevalier, Edwin Choy, Gregory M Cote, Xin Gao, Dejan Juric, Kerry L Reynolds. A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.The oncologist. 2023, 28 (12): 1094-1099
Yaxin Liu, Guohong Song, Lijun Di, Hanfang Jiang, Ran Ran, Ruyan Zhang, Yan Zhang, Huiping Li. Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study.The oncologist. 2023, 28 (12): 1102-e1302
Yuanming Xu, Natalie Wen, Robert I Haddad, Stephen T Sonis, Alessandro Villa. Comparisons of Nonoral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.The oncologist. 2023, :
Eriko Tokunaga, Yasuo Miyoshi, Koji Dozono, Tsutomu Kawaguchi, Masakazu Toi. Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial.The oncologist. 2023, :
Adriana M Kahn, Curtis J Perry, Katrina Etts, Harriet Kluger, Mario Sznol. Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.The oncologist. 2023, :
Ronald Chow, Hannah Drkulec, James H B Im, Jane Tsai, Abdulwadud Nafees, Swetlana Kumar, Tristan Hou, Rouhi Fazelzad, Natasha B Leighl, Monika Krzyzanowska, Philip Wong, Srinivas Raman. The Use of Wearable Devices in Oncology Patients: A Systematic Review.The oncologist. 2023, :
Sara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, Sumadi Luckman Anwar, Chiara Casadei, Ugo De Giorgi, Gabriele Madonna, Paolo Antonio Ascierto, Rossana Veronica Mendoza López, Roger Chammas, Mariaelena Capone. Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.The oncologist. 2023, :
Rana R McKay, Katharina Leucht, Wanling Xie, Opeyemi Jegede, David A Braun, Michael B Atkins, Marc-Oliver Grimm, Toni K Choueiri. A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.The oncologist. 2023, :
Chan Shen, J Douglas Thornton, Ning Li, Eric Schaefer, Shouhao Zhou, Sarah Kawasaki, Colette Pameijer, Douglas Leslie. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States.The oncologist. 2023, :
Lorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, Paolo D'Amico, Carolina Reduzzi, Fabio Puglisi, Massimo Cristofanilli. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.The oncologist. 2023, :
Richard A Newcomb, P Connor Johnson, Daniel Yang, Katherine Holmbeck, Joanna Choe, Anisa Nabily, Porsha Lark, Tejaswini Dhawale, Hermioni L Amonoo, Areej El-Jawahri. Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma.The oncologist. 2023, :
Fidel Rubagumya, Brooke Wilson, Achille Manirakiza, Emmanuel Mutabazi, Diane A Ndoli, Emmanuel Rudakemwa, Mary D Chamberlin, Wilma M Hopman, Christopher M Booth. Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda.The oncologist. 2023, :
Christina Vivelo, Karlyne M Reilly, Brigitte C Widemann, Mary Frances Wedekind, Corrie Painter, Allison F O'Neill, Sabine Mueller, Olivier Elemento, Andrea M Gross, Abby B Sandler. The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review.The oncologist. 2023, :